Jpmorgan Chase & Co »

Maplight Therapeutics shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Maplight Therapeutics (MPLT) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Maplight Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Maplight Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Maplight Therapeutics by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2026-06-30 $149k 4.3k 34.30
2026-03-31 $147k 7.9k 18.71

More positions owned by Jpmorgan Chase & Co

Nvidia Corporation Common (NVDA)
Apple Common (AAPL)
Microsoft Corp Common (MSFT)
Alphabet Common (GOOG)
Amazon Common (AMZN)
Broadcom Common (AVGO)
State Street Spdr S&p 500 Etf Fund (SPY)
Alphabet Common (GOOGL)
Micron Technology Common (MU)
Meta Platforms Common (META)
Advanced Micro Devices Common (AMD)
Lam Research Corp Common (LRCX)
Tesla Common (TSLA)
Vanguard S&p 500 Etf Fund (VOO)
Eli Lilly & Co Common (LLY)

View all positions for Jpmorgan Chase & Co

Top funds holding Maplight Therapeutics

Novo A/S
Fcpm Iii Services B.v.
Goldman Sachs Group
BlackRock
Nan Fung Group Holdings
5AM Venture Management
Sanofi
FMR
Vanguard Capital Management
Blue Owl Capital Holdings
Paradigm Biocapital Advisors
Pivotal bioVenture Partners Investment Advisor
Velan Capital Investment Management
Siren
Geode Capital Management

View all funds holding Maplight Therapeutics